Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 193

Loadsmart plays clever for $19m

Freight services portal Loadsmart has now raised more than $53m in total, having secured new funding from investors including Ports America and Maersk Growth.

Sep 9, 2019

Daily deal net: September 9, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 9, 2019

Leyue Health lays out $16.1m series B

Chinese Academy of Sciences’ Investment Management unit put up a share of the proceeds for health insurance data analytics company Leyue Health’s series B round.

Sep 9, 2019

Terramera takes $45m in series B round

The Ikea, Sumitomo and The Andersons-backed pest control product supplier has closed new funding, in a round led by Ospraie Ag Science.

Sep 9, 2019

Corporate venturing deal net: 2-6 September 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sep 6, 2019

Repare wraps up series B round

Celgene-backed Repare Therapeutics secured $82.5m that will support the entry of its first cancer drug into clinical trials.

Sep 6, 2019

Neura lures corporates to $16m series B

The app engagement software developer raised the funding in a Liberty Technology Venture Capital-led round featuring Amdocs and existing investor Axa.

Sep 5, 2019

Passage Bio packs in another $110m

University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

Sep 5, 2019

Cartica AI clinches series B funding

Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.

Sep 5, 2019

Nkarta inks $114m series B deal

Nkarta, which is developing cell therapy treatments for cancer, has emerged from stealth with $114m in a round featuring Novo, Amgen Ventures and SR One.

Sep 5, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here